Terms: = Bone cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Clinical Outcome
4 results:
1. Resistance to immune checkpoint inhibitors in advanced lung cancer: clinical characteristics, potential prognostic factors and next strategy.
Zhou J; Lu X; Zhu H; Ding N; Zhang Y; Xu X; Gao L; Zhou J; Song Y; Hu J
Front Immunol; 2023; 14():1089026. PubMed ID: 36776868
[TBL] [Abstract] [Full Text] [Related]
2. Synchronous lung and multiple soft tissue metastases developed from osteosarcoma of tibia: a rare case report and genetic profile analysis.
Zheng C; Wang Y; Luo Y; Pang Z; Zhou Y; Min L; Tu C
BMC Musculoskelet Disord; 2022 Jan; 23(1):74. PubMed ID: 35057767
[TBL] [Abstract] [Full Text] [Related]
3. Combined point mutation in KRAS or EGFR genes and EML4-alk translocation in lung cancer patients.
Jürgens J; Engel-Riedel W; Prickartz A; Ludwig C; Schildgen O; Tillmann RL; Stoelben E; Brockmann M; Schildgen V
Future Oncol; 2014 Mar; 10(4):529-32. PubMed ID: 24754584
[TBL] [Abstract] [Full Text] [Related]
4. Anaplastic large cell lymphomas presented as bone lesions: a clinicopathologic study of six cases and review of the literature.
Nagasaka T; Nakamura S; Medeiros LJ; Juco J; Lai R
Mod Pathol; 2000 Oct; 13(10):1143-9. PubMed ID: 11048810
[TBL] [Abstract] [Full Text] [Related]
